Scientists Target Protein to Prevent Diabetic Blindness Before It Starts

UCL Breakthrough Could Intercept Disease in 537 Million People Worldwide

In a discovery that could protect millions from preventable blindness, UCL researchers have identified the biological trigger that begins diabetic eye disease—and developed a drug to stop it before vision loss occurs.
The culprit is LRG1, a protein that constricts tiny blood vessels in the retina during the earliest stages of diabetic retinopathy. By the time patients notice vision problems, irreversible damage has already occurred. But in mouse studies, blocking LRG1 prevented early retinal damage entirely, suggesting intervention could begin years before symptoms appear.
This represents a profound shift from reactive to preventive medicine. Currently, diabetic retinopathy treatment begins only after blood vessels have already leaked or grown abnormally, helping just half of patients. The UCL approach could intercept disease progression at its source, potentially saving sight in the nearly one-third of diabetic patients who develop retinal complications.
The researchers have already developed an LRG1-targeting drug ready for human clinical trials, moving unusually quickly from lab discovery to potential treatment. If successful, it could become standard preventive care for the 537 million people worldwide living with diabetes.

Key Facts

• LRG1 protein identified as earliest trigger of diabetic retinopathy
• 100% prevention of early retinal damage in mouse studies
• Drug candidate ready for human clinical trials
• 537 million people worldwide have diabetes
• Nearly one-third develop diabetic retinopathy
• Current treatments work for only 50% of patients

Why This Matters

This development represents a significant advancement in health & medicine, potentially improving outcomes for millions of patients worldwide.

What We Don't Know Yet

While results are promising, long-term safety data and real-world effectiveness still need validation through larger studies and continued monitoring.

Published March 08, 2026 · Category: Health & Medicine